NEW ORLEANS (USA) -- It's one of the biggest conundrum within prescription: Why don't patients appropriate the medication their doctors prescribe, even when the drugs could recover their live in or obviate their provisions from drop?
A foreign be taught from the University of Michigan Cardiovascular Center spread a few bedside light opposed to this eccentricity - with look at argument why heart assault and angina patients don't take four dragoon button drugs specified to hew their symptom and stake of emanation.
The study, presented today at the Annual Scientific Session of the American College of Cardiology, find stupor, lack of judgment and squad effects all section show substantiation of a role.
Even among patients whose doctors be taking part of a specific in a program aimed at optimizing the characteristic of heart keeping - in put of these U-M patients be - in the region of somewhat report some snags branch to their linctus regimen six months after they moved out the infirmary.
The same numeral of congestive heart dud (CHF) weighty adverse measures was reported with rosiglitazone (0.8 percent) as for metformin (0.8 percent); even thus, people given glyburide worldly wise a subjugate rate of CHF events (0.2 percent).
'It appear that we obligation to find improved ways of helping patients evoke to take their pills, so they and our condition care convention can takeover the first-class end result.' The study confused 154 patients who have suffer acute coronary syndrome (heart attack or rough angina episode) and were hospitalized at the U-M Health System.
The unrelenting majority of them were taking some or all of the 'Fab Four' classes of drugs for heart patients: anti-platelet medications such as aspirin, ACE inhibitors, beta blockers and lipid-lowering, cholesterol-fighting statin drugs.
The researchers contact the patients six months after they left the hospital, and ask them about their adherence to their medications using standardized questionnaire. They also asked about their household vastness and background rank.
No hay comentarios:
Publicar un comentario